Kaletra is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Lopinavir; Ritonavir.
Product ID | 0074-3956_0195c057-8795-448e-b1e4-c168d23e4301 |
NDC | 0074-3956 |
Product Type | Human Prescription Drug |
Proprietary Name | Kaletra |
Generic Name | Lopinavir And Ritonavir |
Dosage Form | Solution |
Route of Administration | ORAL |
Marketing Start Date | 2010-06-18 |
Marketing Category | NDA / NDA |
Application Number | NDA021251 |
Labeler Name | AbbVie Inc. |
Substance Name | LOPINAVIR; RITONAVIR |
Active Ingredient Strength | 80 mg/mL; mg/mL |
Pharm Classes | Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2010-06-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021251 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-06-18 |
Ingredient | Strength |
---|---|
LOPINAVIR | 80 mg/mL |
SPL SET ID: | 8290add3-4449-4e58-6c97-8fe1eec972e3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0074-0522 | Kaletra | Lopinavir and Ritonavir |
0074-1575 | Kaletra | Lopinavir and Ritonavir |
0074-2605 | Kaletra | Lopinavir and Ritonavir |
0074-3956 | Kaletra | Lopinavir and Ritonavir |
0074-6799 | Kaletra | Lopinavir and Ritonavir |
11819-342 | Kaletra | Lopinavir and Ritonavir |
21695-362 | Kaletra | lopinavir and ritonavir |
53808-0276 | Kaletra | lopinavir and ritonavir |
55289-947 | Kaletra | Lopinavir and Ritonavir |
68258-1972 | Kaletra | Kaletra |
70518-0091 | Kaletra | Kaletra |
66336-624 | Kaletra | Kaletra |
68071-2348 | Kaletra | Kaletra |
31722-556 | Lopinavir and ritonavir | Lopinavir and ritonavir |
31722-603 | Lopinavir and ritonavir | Lopinavir and ritonavir |
42385-933 | Lopinavir and Ritonavir | Lopinavir and Ritonavir |
42385-934 | Lopinavir and Ritonavir | Lopinavir and Ritonavir |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KALETRA 75465750 2451327 Live/Registered |
ABBVIE INC. 1998-04-09 |